What is Artiva Biotherapeutics, Inc.'s net change in cash?

Artiva Biotherapeutics, Inc. (ARTV) reported net change in cash of -$5.75M in Q1 2026.

How has Artiva Biotherapeutics, Inc.'s net change in cash changed year-over-year?

Artiva Biotherapeutics, Inc.'s net change in cash increased by 40.3% year-over-year, from -$9.63M to -$5.75M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Artiva Biotherapeutics, Inc. ARTV Net Change in Cash

Net Change in Cash at other companies

Bristol-Myers SquibbBMY

-$635M-220%

Gilead SciencesGILD

$65M+103%

Kyverna Therapeutics, Inc.KYTX

-$91.9M-131%

Allogene TherapeuticsALLO

-$21.38M+34.7%

Immix Biopharma, Inc.IMMX

-$14.68M-734%

ImmunityBio, Inc.IBRX

$117.04M+241%

Other financials

Income statement

See full

Revenue-—

Operating income-$24.4M-10.2%

Net income-$23.5M-15.8%

EPS (diluted)-$0.95-14.5%

Balance sheet

See full

Cash & equivalents$21.4M-30.6%

Total debt$10.3M-26.7%

Total equity$87.8M-48.0%

Total assets$106.0M-44.6%

Cash flow

See full

Operating cash flow-$21.0M-5.6%

CapEx$242.0K-52.6%

Free cash flow-$21.2M-4.1%

Valuation

See full

Market cap$429.03M+1,015%

Enterprise value$417.88M+1,832%

Profitability

See full

Operating margin-83.9%—

Net margin-79.3%—

Returns & leverage

See full

Return on equity-67.9%—

Debt / equity0.1×0.0×

Current ratio8.2×-5.8×

Where this comes from

Reported directly by Artiva Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s net change in cash?: Artiva Biotherapeutics, Inc. (ARTV) reported net change in cash of -$5.75M in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s net change in cash changed year-over-year?: Artiva Biotherapeutics, Inc.'s net change in cash increased by 40.3% year-over-year, from -$9.63M to -$5.75M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.